New injection tested for severe skin condition
Disease control
Recruiting now
This early-stage study is testing a new injectable drug called TRB-061 to see if it's safe for people. First, healthy volunteers will receive single or multiple doses. Then, people with moderate-to-severe eczema will receive four injections over 12 weeks to check for side effects…
Phase: PHASE1 • Sponsor: TRex Bio, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC